| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |